Results

eNauka >  Results >  Impact of age of subjects on the efficacy and safety of once-daily oral obefazimod in moderately to severely active ulcerative colitis: week 8 results from the ABTECT-1 and ABTECT-2 Phase 3, double-blind, placebo-controlled induction trials
Title: Impact of age of subjects on the efficacy and safety of once-daily oral obefazimod in moderately to severely active ulcerative colitis: week 8 results from the ABTECT-1 and ABTECT-2 Phase 3, double-blind, placebo-controlled induction trials
Authors: Magro, F; Tilg, H; Cataldi, F; Jacobstein, D; Rabbat, C; Shan, K; Nancey, S; Markovic, S; Rocco, R; Harlacher, L;
Yarur, A;
Issue Date: 2026
Publication: JOURNAL OF CROHNS & COLITIS
ISSN: 1873-9946 Journal of Crohn#s and Colitis Search Idenfier
Type: Conference Paper
Collation: vol. 20 br. Supplement_1
DOI: 10.1093/ecco-jcc/jjaf231.1229
WoS-ID: 001666548100001
URI: https://enauka.gov.rs/handle/123456789/1027568
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

Altmetric
Dimensions
Unpaywall

Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.